[
  {
    "ts": null,
    "headline": "Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls",
    "summary": "Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=6c1c0dd65e7beb4858eef87b03538d1d8d39418705dfa9a1bd483e85648e6fc7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765291068,
      "headline": "Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls",
      "id": 137740184,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Synopsys upgraded, Warner Bros. downgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=6c1c0dd65e7beb4858eef87b03538d1d8d39418705dfa9a1bd483e85648e6fc7"
    }
  },
  {
    "ts": null,
    "headline": "Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy",
    "summary": "Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ~5%,” but only as certain end markets recover faster than others.",
    "url": "https://finnhub.io/api/news?id=816aafe60d042584179112cfaf041dd52bb6547997b0a27c52f96123b6214bc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765286218,
      "headline": "Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy",
      "id": 137740198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ~5%,” but only as certain end markets recover faster than others.",
      "url": "https://finnhub.io/api/news?id=816aafe60d042584179112cfaf041dd52bb6547997b0a27c52f96123b6214bc8"
    }
  },
  {
    "ts": null,
    "headline": "Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack",
    "summary": "The Investment Committee debate the latest Calls of the Day.",
    "url": "https://finnhub.io/api/news?id=6888c2c54723bb04edb3c5d67e07b46808bd427cf6affceefa0528189bbdc1be",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765284326,
      "headline": "Calls of the Day: Netflix, Thermo Fisher, Incyte and Shake Shack",
      "id": 137748347,
      "image": "https://image.cnbcfm.com/api/v1/image/108239182-17653017931765301790-42902890008-1080pnbcnews.jpg?v=1765301792&w=1920&h=1080",
      "related": "TMO",
      "source": "CNBC",
      "summary": "The Investment Committee debate the latest Calls of the Day.",
      "url": "https://finnhub.io/api/news?id=6888c2c54723bb04edb3c5d67e07b46808bd427cf6affceefa0528189bbdc1be"
    }
  },
  {
    "ts": null,
    "headline": "DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030",
    "summary": "The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid biopsies, the rise of direct-to-consumer testing, the shift to smart bioinformatics, and advancements in genomics and personalized medicine. Increasing genetic disorder prevalence, improved DNA sequencing technology, and expanded diagnostic applications further fuel market expansion. North America leads",
    "url": "https://finnhub.io/api/news?id=8b0b305c14a124e1a2d1312aee5b28ff4f0e6b71de5a8840c54710e31e60afbd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765275780,
      "headline": "DNA Diagnostics Market Projected to Surge by 66% to USD 21.69 Billion by 2030",
      "id": 137740196,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TMO",
      "source": "Yahoo",
      "summary": "The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of 8.81%. Key trends driving this growth include the emergence of liquid biopsies, the rise of direct-to-consumer testing, the shift to smart bioinformatics, and advancements in genomics and personalized medicine. Increasing genetic disorder prevalence, improved DNA sequencing technology, and expanded diagnostic applications further fuel market expansion. North America leads",
      "url": "https://finnhub.io/api/news?id=8b0b305c14a124e1a2d1312aee5b28ff4f0e6b71de5a8840c54710e31e60afbd"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Tuesday",
    "summary": "Stocks were little changed early this morning after a down session for Wall Street. Traders are awaiting the Fed's next interest rate decision.",
    "url": "https://finnhub.io/api/news?id=d1e40cbed388b388cf8cf780c69e86c3ba833b8b4b0630810eb03e9017419e58",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765269928,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Tuesday",
      "id": 137741601,
      "image": "https://image.cnbcfm.com/api/v1/image/108222121-17623850772025-11-05t230736z_214248853_rc2lqhae98m2_rtrmadp_0_britain-royals-king.jpeg?v=1762385223&w=1920&h=1080",
      "related": "TMO",
      "source": "CNBC",
      "summary": "Stocks were little changed early this morning after a down session for Wall Street. Traders are awaiting the Fed's next interest rate decision.",
      "url": "https://finnhub.io/api/news?id=d1e40cbed388b388cf8cf780c69e86c3ba833b8b4b0630810eb03e9017419e58"
    }
  },
  {
    "ts": null,
    "headline": "Keybanc Upgrades Thermo Fisher Scientific (TMO)",
    "summary": "Keybanc Upgrades Thermo Fisher Scientific (TMO)",
    "url": "https://finnhub.io/api/news?id=241a38b643c5e29933dc0fe71ca9276b99e98b7bd96b49476c3db93b3bbd1e98",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765238727,
      "headline": "Keybanc Upgrades Thermo Fisher Scientific (TMO)",
      "id": 137735377,
      "image": "",
      "related": "TMO",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=241a38b643c5e29933dc0fe71ca9276b99e98b7bd96b49476c3db93b3bbd1e98"
    }
  }
]